[
  {
    "date": "2023-12-30",
    "symbol": "ELVN",
    "period": "FY",
    "netincomeloss": -71584000,
    "trdarrsecuritiesaggavailamt": 110000,
    "entityregistrantname": "ENLIVEN THERAPEUTICS, INC.",
    "documenttype": "10-K",
    "tradingsymbol": "ELVN",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1672619,
    "entityfilercategory": "Non-accelerated Filer",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "security12btitle": "Common Stock, $0.001 par value per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39247",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "81-1523849",
    "entityaddressaddressline1": "6200 Lookout Road",
    "entityaddresscityortown": "Boulder",
    "entityaddressstateorprovince": "CO",
    "entityaddresspostalzipcode": 80301,
    "cityareacode": 720,
    "localphonenumber": "647-8519",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "auditorname": "Deloitte & Touche LLP",
    "auditorfirmid": 34,
    "auditorlocation": "San Francisco, California",
    "documentfinstmterrorcorrectionflag": "false",
    "cashandcashequivalentsatcarryingvalue": 100141000,
    "marketablesecuritiescurrent": 153007000,
    "restrictedcashcurrent": 54000,
    "prepaidexpenseandotherassetscurrent": 2949000,
    "contingentvaluerightasset": 10000000,
    "assetscurrent": 266151000,
    "propertyplantandequipmentnet": 742000,
    "operatingleaserightofuseasset": 320000,
    "deferredofferingcostsnoncurrent": 563000,
    "otherassetsnoncurrent": 4091000,
    "assets": 271867000,
    "accountspayablecurrent": 532000,
    "accruedexpensesandothercurrentliabilities": 15362000,
    "contingentvaluerightliability": 10000000,
    "liabilitiescurrent": 25894000,
    "otherliabilitiesnoncurrent": 67000,
    "liabilities": 25961000,
    "commonstockvalue": 41000,
    "additionalpaidincapital": 400172000,
    "accumulatedothercomprehensiveincomelossnetoftax": 141000,
    "retainedearningsaccumulateddeficit": -154448000,
    "stockholdersequity": 245906000,
    "liabilitiesandstockholdersequity": 271867000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 41292027,
    "commonstocksharesoutstanding": 41292027,
    "researchanddevelopmentexpense": 64574000,
    "generalandadministrativeexpense": 18955000,
    "operatingexpenses": 83529000,
    "operatingincomeloss": -83529000,
    "interestincomeexpensenonoperatingnet": 11967000,
    "othernonoperatingincomeexpense": -22000,
    "nonoperatingincomeexpense": 11945000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 141000,
    "comprehensiveincomenetoftax": -71443000,
    "earningspersharebasic": -2.01,
    "earningspersharediluted": -2.01,
    "weightedaveragenumberofsharesoutstandingbasic": 35546215,
    "weightedaveragenumberofdilutedsharesoutstanding": 35546215,
    "sharesoutstanding": 41292027,
    "stockissuedduringperiodvaluestockoptionsexercised": 475000,
    "stockissuedduringperiodsharesstockoptionsexercised": 234162,
    "vestingofrestrictedstockunits": 7187,
    "vestingofrestrictedstockandstockoptions": 295000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -149749000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": -61730064,
    "stockissuedduringperiodvaluenewissues": 13000,
    "stockissuedduringperiodsharesnewissues": 12638636,
    "stockissuedduringperiodvalueacquisitions": 7000,
    "stockissuedduringperiodsharesacquisitions": 6625176,
    "adjustmentstoadditionalpaidincapitalchangeincommonstockparvalue": 2000,
    "reverserecapitalizationtransactioncosts": 9044000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 12914000,
    "othercomprehensiveincomelossnetoftax": 141000,
    "paymentsofstockissuancecosts": 4955000,
    "depreciation": 297000,
    "sharebasedcompensation": 12914000,
    "noncashleaseexpense": 306000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 4603000,
    "increasedecreaseinprepaidexpensesother": 3703000,
    "increasedecreaseinoperatingleaseliability": -310000,
    "increasedecreaseinaccountspayable": -2250000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 7664000,
    "netcashprovidedbyusedinoperatingactivities": -61269000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 120000000,
    "paymentstoacquiremarketablesecurities": 268263000,
    "paymentstoacquireproductiveassets": 149000,
    "netcashprovidedbyusedininvestingactivities": -148412000,
    "proceedsfromstockoptionsexercised": 399000,
    "paymentofdeferredofferingcostsrelatedtothesalesagreement": 563000,
    "proceedsfromissuanceofcommonstock": 161365000,
    "proceedsfromcashacquiredinconnectionwithreverserecapitalization": 81821000,
    "paymentsofmergerrelatedcostsfinancingactivities": 8736000,
    "netcashprovidedbyusedinfinancingactivities": 234286000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 24605000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 100195000,
    "restrictedcash": 54000,
    "receivablesfromstockoptionexercisesincludedinprepaidexpensesandothercurrentassets": 76000,
    "conversionofstockamountissued1": 149749000,
    "entityincorporationdateofincorporation": "2019-06-12",
    "cashcashequivalentsandshortterminvestments": 253100000,
    "restrictedcashcollateralofsublease": 54000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P3Y",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2022-01-01",
    "accountingstandardsupdateextensiblelist": "http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201912Member",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "cashandcashequivalentsfairvaluedisclosure": 99388000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 153007000,
    "assetsfairvaluedisclosure": 252395000,
    "contingentvaluerightsagreementasset": 10000000,
    "contingentvaluerightsagreementliability": 10000000,
    "percentageofcvrassetandliabilityuponexpectedprobability": 1,
    "availableforsaledebtsecuritiesamortizedcostbasis": 152866000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 147000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 6000,
    "availableforsalesecuritiesdebtsecurities": 153007000,
    "debtsecuritiesavailableforsalefairvaluematuritiesoneyearorless": "1 or less",
    "areaofleasedofficespace": 18170,
    "leaseandrentalexpense": 300000,
    "lesseeoperatingleaseremainingleaseterm": "P1Y",
    "leasecommencementdate": "2022-07-31",
    "lesseeoperatingleasediscountrate": 4,
    "operatingremainingleaseliability": 300000,
    "operatingleaseremainingrightofuseasset": 300000,
    "variableleasecost": 400000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 341000,
    "lesseeoperatingleaseliabilitypaymentsdue": 341000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 6000,
    "operatingleaseliability": 335000,
    "operatingleaseliabilitystatementoffinancialpositionextensiblelist": "http://www.enliventherapeutics.com/20231231#AccruedExpensesAndOtherCurrentLiabilities",
    "operatingleaseliabilitycurrent": 335000,
    "propertyplantandequipmentgross": 1191000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 671000,
    "depreciationdepletionandamortization": 300000,
    "accruedemployeebenefitscurrent": 3328000,
    "accruedresearchanddevelopmentcostcurrent": 10433000,
    "leaseliabilitycurrent": 335000,
    "accruedprofessionalfeescurrent": 902000,
    "otheraccruedliabilitiescurrent": 364000,
    "commonstocknumberofsharessubjecttorepurchase": 86153,
    "commonstockliabilityrelatedtosharessubjecttorepurchase": 400000,
    "numberofvotebycommonstockholders": 1,
    "stockissuedduringperiodsharesuponexerciseofstockoptionsoutstanding": 5817339,
    "issuanceofcommonstockuponvestingofrestrictedstockunits": 78505,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1574426,
    "commonstockcapitalsharesreservedforfutureissuance": 402757,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawarddescription": "The number of shares reserved shall be annually increased on the first day of each fiscal year, beginning with the fiscal year commencing on January 1, 2024 and continuing until, and including, the fiscal year commencing January 1, 2032, equal to the least of (i) 4.5% of the number of shares of the Company’s common stock outstanding on the first day of such fiscal year and (ii) an amount determined by the Company’s board of directors.",
    "deferredcompensationsharebasedarrangementsliabilitycurrent": 53000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 100000,
    "allocatedsharebasedcompensationexpense": 6000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y10M24D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P0Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 85692,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexercisedinperiodtotalintrinsicvalue": 4500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 15.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5817339,
    "sharebasedcompensationarrangementbysharebasedpaymentawardassumptionofoptionsinconnectionwithmerger": 449900,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2563778,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisedandvestedinperiod": -316194,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandcancelledinperiod": -196816,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2457579,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 5817339,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 11.9,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardassumptionofoptionsinconnectionwithmergerweightedaverageexerciseprice": 28.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 21.65,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisedandvestedinperiodweightedaverageexerciseprice": 2.42,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 28.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 6.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 11.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P6Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 35692000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 24169000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 35692000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 7480,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 42977,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 0.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 14.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 0.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.053,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.033,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.048,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.053,
    "effectiveincometaxratereconciliationpermanentdifferencespercent": 0.003,
    "effectiveincometaxratereconciliationlimitationonexecutivecompensationpercent": 0.015,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.26,
    "effectiveincometaxratereconciliationadjustmentoftaxcreditsandreversal": -0.012,
    "effectiveincometaxratereconciliationotheradjustments": -0.003,
    "deferredtaxassetsgoodwillandintangibleassets": 40000,
    "deferredtaxassetsoperatinglosscarryforwards": 19745000,
    "deferredtaxassetstaxcreditcarryforwards": 1535000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 19313000,
    "deferredtaxassetsstockbasedcompensation": 1370000,
    "deferredtaxassetsaccrualsandotherexpensesnotcurrentlydeductible": 834000,
    "deferredtaxassetsleaseliability": 94000,
    "deferredtaxassetsgross": 42931000,
    "deferredtaxliabilitiespropertyplantandequipment": 55000,
    "deferredtaxliabilitiesrightofuseasset": 90000,
    "deferredincometaxliabilities": 145000,
    "deferredtaxassetsvaluationallowance": 42786000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 23200000,
    "operatinglosscarryforwards": 185300000,
    "operatinglosscarryforwardsnotsubjecttoexpiration": 177300000,
    "operatinglosscarryforwardssubjecttoexpiration": 8000000,
    "operatinglosscarryforwardsexpirationyear": 2037,
    "researchanddevelopmentcreditcarryforwardssubjecttoexpiration": 10500000,
    "researchanddevelopmentcreditcarryforwardsexpirationyear": 2043,
    "reductionindeferredtaxassetsnetoperatinglosscarryforwards": 900000,
    "reductionindeferredtaxassetscreditcarryforwards": 8800000,
    "unrecognizedtaxbenefits": 32100000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 28698000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 3282000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 89000,
    "weightedaveragecommonsharesoutstanding": 35702864,
    "weightedaverageunvestedcommonstockissueduponearlyexerciseofcommonstockoptions": 119154,
    "weightedaveragenumberofsharesrestrictedstock": 37495,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5817339
  }
]